N onalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the United
States and is becoming a significant public health concern worldwide. NAFLD is a hepatic component of the metabolic syndrome, which is characterized by visceral fat accumulation, insulin resistance, dyslipidemia, and hypertension. 1, 2 Although NAFLD is generally a benign liver disease, a subset of NAFLD includes progressive liver disease designated nonalcoholic steatohepatitis (NASH). An emerging concept is that the innate immune system mediates the development of NASH. 3 In NASH, Kupffer cells, hepatic resident macrophages, are the primary cells that produce various inflammatory and fibrogenic mediators, which involve the activation of hepatic stellate cells (HSCs). 4 Activated HSCs produce chemokines, cytokines, and excessive extracellular matrix, resulting in fibrosis. 5, 6 As a component of the innate immune system, Tolllike receptors (TLRs) recognize highly conserved microbial structures as pathogen-associated molecular patterns such as lipopolysaccharide (LPS). 7 Thirteen TLRs have been identified in mammals for host defense against microorganisms. TLRs, except for TLR3, use MyD88, an essential adaptor molecule, to activate transcription factors, such as nuclear factor-B (NF-B), activator protein 1 (AP-1), and interferon regulatory factors that induce inflammatory cytokines and interferon-inducible genes. 7 TLRs are associated with liver diseases, including alcoholic liver injury, ischemic-reperfusion injury, liver fibrosis, and liver cancer. 8 -10 Indeed, mice mutated in TLR4 and MyD88 are resistant to liver damage and fibrosis both in toxin-induced and cholestasis-induced liver injury. 10, 11 Thus, the TLR-MyD88 pathway plays an important role in liver injury and fibrosis as well as host defense.
TLR9 is a receptor for unmethylated cytosine phosphate guanine (CpG)-containing DNA, a major component of bacterial DNA. 7, 12 In chronic liver disease, bacterial DNA is often detected in blood and ascites in both rodents and human beings. 13, 14 Host-derived denatured DNA from apoptotic cells is also recognized by TLR9 as an endogenous ligand. 15, 16 Thus, liver cells might be exposed to high levels of TLR9 ligands after liver injury. Indeed, TLR9 Ϫ/Ϫ mice exhibit reduced liver injury and fibrosis induced by carbon tetrachloride, acetaminophen, and bile duct ligation, indicating that TLR9 plays a crucial role in liver diseases. [15] [16] [17] However, the role of TLR9 in the development of NASH is unknown.
The present study investigated the role of TLR9 and downstream signaling in the setting of steatohepatitis induced by a choline-deficient amino-acid defined (CDAA) diet. We show that TLR9 expression in Kupffer cells and subsequent interleukin-1␤ (IL-1␤) production are important for the development of NASH.
Materials and Methods Animals
Wild-type (WT) C57BL/6 mice and IL-1 receptor (IL-1R) Ϫ/Ϫ mice were purchased from Jackson Laboratories (Bar Harbor, ME). TLR9 Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice backcrossed at least 10 generations onto the C57BL/6 background were a gift from Dr Akira (Osaka University, Japan). 12, 18 These null mice exhibited similar hepatobiliary phenotypes and hepatic lipid contents when fed standard laboratory chow (Supplementary Table 1 ). Male mice were divided into 3 groups at 8 weeks old; standard chow group (PicoLab Rodent Diet 20 series, Catalog no. 5053; LabDiet, Framingham, MA); choline-supplemented L-amino acid defined diet (CSAA; catalog no. 518754; Dyets Inc, Bethlehem, PA); and choline-deficient L-amino acid defined diet (catalog no. 518753; Dyets Inc). 19 Both CSAA and CDAA diets contain higher calories than standard chow (Supplementary Table 2 ). These diets were continued for 22 weeks. In some experiments, Kupffer cells were depleted by liposomal clodronate. 11, 20 Briefly, 200 L of liposomal clodronate was injected into the mice intravenously after 21 weeks of CDAA diet feeding, and then mice were killed 1 week later. The food intake on the CDAA diet was monitored for 1 month. The mice received humane care according to US National Institutes of Health (NIH) recommendations outlined in the "Guide for the Care and Use of Laboratory Animals." All animal experiments were approved by the University of California San Diego Institutional Animal Care and Use Committee.
Histologic Examination
H&E, Oil-Red O, TdT (terminal deoxynucleotidyltransferase)-mediated dUTP (2=-deoxyuridine 5=-triphosphate)-biotin neck end labeling (TUNEL), and Sirius red staining were performed. 11, 21 TUNEL-positive cells were counted on 10 high power (400ϫ) fields/slide. The Sirius red-positive area was measured on 10 low power (40ϫ) fields/slide and quantified with the use of NIH imaging software. NAFLD activity score was determined as described. 22 Immunohistochemistry for F4/80, desmin, and CD31 was performed. 11
Quantitative Real-Time Polymerase Chain Reaction Analysis
Extracted RNA from livers and cells was subjected to reverse transcription and subsequent quantitative realtime polymerase chain reaction (PCR) with the use of ABI PRISM 7000 Sequence Detector (Applied Biosystems). 11 PCR primer sequences are listed in Supplementary Table  3 . Genes were normalized to 18S RNA as an internal control.
Lipid Isolation and Measurement
Triglyceride, total cholesterol, and free fatty acid contents were measured with the use of Triglyceride Reagent Set (Pointe Scientific, Canton, MI), Cholesterol E (Wako, Richmond, VA), free fatty acid, and half micro test (Roche, Mannheim, Germany).
Assessment of Insulin Resistance
Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as [immunoreactive insulin (U/mL) ϫ fasting blood sugar (mg/dL) Ϭ 405]. 23 
Cell Isolation and Treatment
Hepatocytes, HSCs, and Kupffer cells were isolated from mice as previously described. 11, 21 After cell attachment, hepatocytes were serum starved for 16 hours. The culture media for Kupffer cells and HSCs were changed to 1% serum for 16 hours followed by treatment with 10 ng/mL IL-1␤, 5 g/mL CpG-oligodeoxynucleotide (ODN; ODN1826: 5=-tccatgacgttcctgacgtt-3=), and 5 g/mL non-CpG-ODN (5=-tccatgagcttcctgagctt-3=). Liver cells were fractionated into 4 cell populations (hepatocytes, Kupffer cells, endothelial cells, and HSCs) as described. 19 
Assessment of Cell Death
Apoptosis and necrosis were determined with the use of Hoechst33342 (Invitrogen, San Diego, CA) and propidium iodide staining as described. 21 
Adenoviruses
For measurement of NF-B activation, a recombinant adenovirus expressing a luciferase reporter gene driven by NF-B activation was used. 11, 24 To inhibit NF-B activation, a recombinant adenovirus expressing inhibitor of NF-B (IB) super-repressor was used. 11, 21, 24 
Measurement for IL-1␤
Enzyme-linked immunoabsorbent assay kit (R&D Systems, Minneapolis, MN) was used for measuring IL-1␤ in serum and supernatant.
Western Blot Analysis
Supernatant or protein extracts (20 L) were electrophoresed and then blotted. Blots were incubated with antibody for tissue inhibitor of metalloproteinase-1 (TIMP1; R&D Systems) or IL-1R-associated kinase M (IRAK-M; Cell Signaling Technology Inc, Danvers, MA). 11, 24 
Statistical Analysis
Differences between the 2 groups were compared with Mann-Whitney U test. Differences between multiple groups were compared with 1-way analysis of variance (GraphPad Prism 4.02; GraphPad Software Inc, San Diego, CA). A P value of Ͻ.05 was considered significant.
Results

TLR9 Signaling Induces Steatohepatitis and Fibrosis
We investigated the contribution of TLR9 in a murine model of NASH. WT and TLR9 Ϫ/Ϫ mice were fed a CDAA or control CSAA diet for 22 weeks. WT mice had marked lipid accumulation with inflammatory cell infiltration, hepatocyte death, and liver fibrosis ( Figure 2) . The NAFLD activity score, as determined by the degree of steatosis, inflammation, and ballooning, was significantly lower in TLR9 Ϫ/Ϫ mice than in WT mice (total score, WT vs TLR9 Ϫ/Ϫ mice ϭ 6.5 vs 2.6; P Ͻ .01) ( Figure 1D ). 22 Reduced steatosis and liver injury in TLR9 Ϫ/Ϫ mice were confirmed by lower levels of hepatic triglyceride and serum alanine transaminase (ALT; Figure 1E ). In accordance with reduced liver fibrosis examined by Sirius red staining, mRNA levels of collagen ␣1(I), collagen ␣1(IV), TIMP1, plasminogen activator inhibitor-1 (PAI-1), and transforming growth factor ␤ (TGF␤) were markedly suppressed in TLR9 Ϫ/Ϫ mice ( Figure 1F ). These results suggest that TLR9 signaling is required for the progression of NASH.
Kupffer Cell-Derived IL-1␤ Is Suppressed in TLR9 ؊/؊ Mice
To determine the key molecules responsible for the attenuated steatohepatitis in TLR9 Ϫ/Ϫ mice, we examined hepatic mRNA expression of inflammatory cytokines, including tumor necrosis factor ␣ (TNF␣), IL-6, IL-1␣ and IL-1␤, mRNA levels of inflammatory cytokines in mice deficient in MyD88, an adaptor molecule for TLR9 signaling, were completely suppressed after CDAA diet feeding (Figure 2A ). Among these inflammatory cytokines, the IL-1␤ mRNA level was significantly suppressed in TLR9 Ϫ/Ϫ mice ( Figure 2A ). TLR9 Ϫ/Ϫ mice showed a similar reduction of the serum IL-1␤ level of MyD88 Ϫ/Ϫ mice ( Figure 2B ), suggesting that TLR9-dependent MyD88-mediated IL-1␤ is an important factor in the progression of NASH.
Because Kupffer cells are a primary source of IL-1␤ in some models of liver injury, 25, 26 we determined the role of Kupffer cells in IL-1␤ production. Intravenous injection of liposomal clodronate exclusively depleted Kupffer cells, but not HSCs or sinusoidal endothelial cells (Supplementary Figure 3 ). IL-1␤ levels were significantly reduced at 1 week after the liposomal clodronate injection after 21 weeks on the CDAA diet ( Figure 2C ). In addition, we isolated hepatocytes, Kupffer cells, HSCs, and sinusoidal endothelial cells from WT mice after 22 weeks on the CDAA diet. High levels of IL-1␤ mRNA expression were observed only in the Kupffer cell fraction ( Figure  2D ). These data indicate that Kupffer cells are the main source of IL-1␤ in the CDAA diet.
Next, we tested whether a CpG-containing ODN, a synthetic TLR9 ligand, induces IL-1␤ production in Kupffer cells. A CpG-ODN up-regulated IL-1␤ mRNA in WT Kupffer cells but not in TLR9 Ϫ/Ϫ or MyD88 Ϫ/Ϫ Kupffer cells ( Figure 2E ). On activating caspase-1 with adenosine triphosphate (ATP), 27 WT Kupffer cells secrete the active form of IL-1␤ ( Figure 2E ). In contrast, CpG-ODN did not induce IL-1␤ mRNA in either HSCs or hepatocytes isolated from WT mice, and the active form of IL-1␤ was not detected in culture supernatant from HSCs and hepatocytes (data not shown). These results indicate that IL-1␤ is primarily produced from Kupffer cells through TLR9 in NASH induced by the CDAA diet.
IL-1␤ Enhances Lipid Accumulation and Hepatocyte Injury
To determine the effect of IL-1␤ on NASH, we examined whether IL-1␤ affects lipid metabolism in hepatocytes. IL-1␤ increased lipid droplet and triglyceride content in WT and TLR9 Ϫ/Ϫ -cultured hepatocytes, but not IL-1R Ϫ/Ϫ hepatocytes ( Figure 3A and B) . mRNA expression of diacylglycerol acyltransferase 2 (DGAT2), an enzyme that converts diglyceride to triglyceride, was up-regulated in WT and TLR9 Ϫ/Ϫ hepatocytes, but not in IL-1R Ϫ/Ϫ hepatocytes, after IL-1␤ treatment ( Figure 3C ). These results indicate that IL-1␤ induces lipid accumulation in hepatocytes.
Next, we investigated the contribution of IL-1␤ to hepatocyte death. In hepatocytes isolated from mice fed the CSAA diet, IL-1␤ did not induce cell death ( Figure  3D, right) . However, IL-1␤ increased apoptosis and necrosis in lipid-accumulated hepatocytes isolated from mice fed the CDAA diet ( Figure 3D, left and right) . In response to IL-1␤, ALT and lactate dehydrogenase (LDH) levels were elevated in supernatant from hepatocytes of mice fed the CDAA diet but not hepatocytes of mice fed the CSAA diet ( Figure 3E ). IL-1␤ increased the expression of antiapoptotic gene Bcl2, but not proapoptotic gene Bax, in hepatocytes of mice fed the CSAA diet. Importantly, Bax, but not Bcl2, expression was up-regulated in hepatocytes of mice fed the CDAA diet after IL-1␤ treatment ( Figure 3F, left) . NF-B activation has an essential antiapoptotic effect in hepatocytes. 21 IL-1␤ increased NF-B activation in hepatocytes of mice fed the CSAA diet. Notably, NF-B activation was blunted in hepatocytes of mice fed the CDAA diet after IL-1␤ treatment ( Figure 3F , right). To determine the direct role of NF-B in cell death induced by IL-1␤, NF-B activation was inhibited by an IB super-repressor in hepatocytes. With the inhibition of NF-B activation, IL-1␤ increased hepatocyte apoptosis and the levels of ALT and LDH ( Supplementary Figure 4A-C) , indicating that NF-B inactivation is crucial for determining the susceptibility of cell death in lipidaccumulated hepatocytes.
We also tested the direct effect of TLR9 signaling on hepatocytes. However, CpG-ODN had little effect on lipid accumulation and cell death in either normal hepatocytes or lipid-accumulated hepatocytes (Supplementary Figure 5A-J) . These results indicate that IL-1␤ mediates lipid accumulation and cell death in hepatocytes during NASH.
IL-1␤ Promotes the Activation of HSCs
Next, we examined whether IL-1␤ mediates fibrogenic responses in HSCs, the main precursors of myofibro- (Supplementary Figure 6) . To determine the functional role of IL-1␤ secreted from Kupffer cells, HSCs were incubated with conditioned medium derived from Kupffer cells treated with CpG-or non-CpG-ODN. Conditioned medium from cells treated with CpG-ODN, but not with non-CpG-ODN, increased TIMP1 and PAI-1 levels in WT and TLR9 Ϫ/Ϫ HSCs. Notably, IL-1R Ϫ/Ϫ HSCs did not increase TIMP1 and PAI-1 levels in response to CpG-ODNtreated conditioned medium ( Figure 4E ). These results suggest that TLR9-mediated IL-1␤ released from Kupffer cells is essential for HSC activation.
IL-1R ؊/؊ Mice Exhibit Reduced Steatosis, Hepatocyte Damage, and Fibrosis
To confirm the critical role of IL-1R signaling in NASH, IL-1R Ϫ/Ϫ mice were fed a CDAA diet for 22 weeks. IL-1R Ϫ/Ϫ mice exhibited less steatosis, apoptosis, and liver fibrosis ( Figure 5A-C) . The NAFLD activity score in IL-1R Ϫ/Ϫ mice was significantly lower than that in WT mice (total score, WT vs IL-1R Ϫ/Ϫ mice ϭ 6.5 vs 4.6; P Ͻ .05); in particular, the scores for steatosis and hepatocyte ballooning but not inflammatory cell infiltration were smaller in IL-1R Ϫ/Ϫ mice ( Figure 5D ). Reduced steatosis was shown by decreased hepatic triglyceride content ( Figure 5E ). ALT levels were lower in IL-1R Ϫ/Ϫ mice ( Figure 5E ). Reduced liver fibrosis was confirmed by decreased mRNA levels of collagen ␣1(I), collagen ␣1(IV), TIMP1, and PAI-1 ( Figure 5F ). These findings indicate that IL-1R signaling contributes to steatosis, hepatocyte damage, and fibrosis.
MyD88 Is a Critical Component for the Development of Steatohepatitis and Fibrosis
Because TLR9 and IL-1R signaling share the adaptor molecule MyD88, we investigated the role of MyD88 (E, right) . Data represent mean Ϯ SD; *P Ͻ .05, **P Ͻ .01; n.s., not significant.
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in NASH. Steatosis, inflammation, apoptosis, and fibrosis were remarkably inhibited in MyD88 Ϫ/Ϫ mice fed a CDAA diet (Figure 6A-C) . The NAFLD activity score was significantly lower in MyD88 Ϫ/Ϫ mice (total score, WT vs MyD88 Ϫ/Ϫ ϭ 6.5 vs 2.0; P Ͻ .01), and every score was significantly less than that in WT mice ( Figure 6D ). Hepatic triglyceride and serum ALT levels were markedly reduced in MyD88 Ϫ/Ϫ mice ( Figure 6E ). In addition, MyD88 Ϫ/Ϫ mice had decreased mRNA levels of collagen ␣1(I), collagen ␣1(IV), TIMP-1, and PAI-1 ( Figure 6F ). These results implicate MyD88 as a crucial signaling molecule that promotes NASH and fibrosis.
TLR9 Signaling Mediates Insulin Resistance Induced by CDAA Diet
Insulin resistance is observed in most patients with NASH. 2 Therefore, we assessed HOMA-IR levels in TLR9 Ϫ/Ϫ , IL-1R Ϫ/Ϫ , and MyD88 Ϫ/Ϫ mice. A significant reduction of HOMA-IR was seen in TLR9 Ϫ/Ϫ mice compared with that in WT mice receiving a CDAA diet (Figure 7) . Furthermore, HOMA-IR was not increased in IL-1R Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice on a CDAA or CSAA diet compared with that in mice fed standard chow ( Figure  7) . These results indicate that TLR9, IL-1R, and MyD88 are crucial for the development of insulin resistance. However, both the CDAA and CSAA diets significantly increased the HOMA-IR level compared with standard chow in WT mice. The CDAA diet feeding resulted in NASH, whereas the CSAA diet feeding produced mild steatosis, indicating that insulin resistance is not correlated with the degree of NASH, which further suggests that insulin resistance may be associated with steatosis, but additional mediators through TLR9, IL-1R, and MyD88 are required for the development of NASH.
Discussion
The present study shows that steatohepatitis is diminished in TLR9 Ϫ/Ϫ , IL-1R Ϫ/Ϫ , and MyD88 Ϫ/Ϫ mice. Kupffer cells, but not hepatocytes and HSCs, respond to TLR9 ligands to produce IL-1␤. This IL-1␤ induces lipid accumulation and cell death in hepatocytes and the expression of fibrogenic mediators in HSCs, resulting in steatosis, hepatocyte injury, and fibrosis ( Figure 7B) .
Two possible mechanisms activate innate immune systems in NASH. First, translocated bacteria and their products activate the innate immune network as exoge- nous ligands in NASH. [7] [8] [9] 28 In chronic liver disease, including NASH, intestinal permeability is increased because of bacterial overgrowth or altered composition of bacterial microflora. 29 Systemic inflammation related to NASH also injures epithelial tight junctions, 30 resulting in deregulation of intestinal barrier functions. Indeed, plasma levels of LPS are elevated in patients with chronic liver diseases, including NASH. 31 We and others have reported that TLR4, a receptor for LPS, promotes steatohepatitis and fibrosis. 4, 8 Bacterial DNA was also detected by PCR for bacterial 16S rRNA in the blood of mice fed a CDAA diet (data not shown), suggesting that translocated bacterial DNA could be an exogenous ligand in NASH. Second, dying hepatocytes in NASH supply denatured host DNA that may activate TLR9 as an endogenous ligand. 16 Thus, exogenous and endogenous TLR9 ligands may activate the innate immune system through TLR9, which results in the development of steatohepatitis, fibrosis, and insulin resistance.
The prominent features of hepatocytes in NASH are excessive lipid accumulation and cell death. We determined that IL-1␤ promotes lipid accumulation and triglyceride synthesis by up-regulating DGAT2 in hepatocytes. Increased triglyceride accumulation by IL-1␤ was observed in TLR9 Ϫ/Ϫ hepatocytes in vitro, indicating that lipid accumulation depends on IL-1␤, but not TLR9, in hepatocytes. Our data suggest that a low level of IL-1␤ is associated with reduced lipid accumulation in hepatocytes of TLR9 Ϫ/Ϫ mice. We found that lipid-laden hepatocytes had blunted activation of NF-B. Meanwhile, the expression of IRAK-M, a negative regulator of IL-1R signaling, 7 was increased in lipid-laden hepatocytes (Supplementary Figure 7) . As a result, lipid-laden hepatocytes are sensitive to IL-1␤-induced cell death. Previous studies have shown that IL-1R antagonist-deficient mice on a high-fat diet have more severe steatohepatitis. 32 In addition, an IL-1␤ gene polymorphism is prevalently observed in patients with NASH. 33 These studies are consistent with our conclusion that IL-1␤ is important for the progression of NASH.
IL-1␤ contributes to HSC activation by regulating fibrogenic factors. Among IL-1␤-mediated profibrogenic factors, HSCs markedly increased the secretion of TIMP1, an inhibitor of matrix metalloproteases, 34 which inhibits degradation of extracellular matrix to promote liver fibrosis. Indeed, transgenic mice overexpressing TIMP1 exhibit severe liver fibrosis induced by the treatment of carbon tetrachloride, 35 and treatment with a neutralizing anti-TIMP1 antibody attenuates liver fibrosis. 34 Moreover, TIMP1 inhibits HSC apoptosis. 36 IL-1␤ induced other fibrogenic factors, including PAI-1, collagen, and decreased the expression of Bambi, a pseudoreceptor for TGF␤. Thus, IL-1␤ plays an important role in fibrogenic responses in NASH. Although HSCs have been reported to be targets for TLR9 ligands, 15, 17 primary cultured HSCs barely responded to CpG-ODN in comparison to IL-1␤ in our study (Supplementary Figure 6) . However, conditioned medium derived from CpG-ODN-treated Kupffer cells strongly induced TIMP-1 expression in WT, but not IL-1R Ϫ/Ϫ HSCs ( Figure 4E ). These findings further confirmed our hypothesis that the critical mediator for HSC activation is IL-1 released from Kupffer cells.
Multiple TLRs and inflammatory cytokines mediate NASH. TLR4 promotes NASH by producing inflammatory cytokines, including TNF-␣ and IL-1␤. 4 A synergistic interaction of TLR4 and TLR9 induces the highest expression of TNF-␣, 37,38 but it has not been reported in the IL-1␤ production. Notably, TLR4 strongly activates caspase-1 that processes the proform of IL-1␤ to active IL-1␤ indepen- Figure 7 . (A) TLR9 -MyD88 -IL-1R axis promotes insulin resistance. Normal chow (N), CSAA (CS), and CDAA (CD) diets were fed to WT, TLR9 ؊/؊ , IL-1R ؊/؊ , and MyD88 ؊/؊ mice for 22 weeks (n ϭ 6, each group). Insulin resistance was examined by HOMA-IR. Data represent mean Ϯ SEM; **P Ͻ .01; n.s., not significant. (B) The proposed mechanism responsible for the development of NASH through TLR9 and IL-1␤. TLR9 ligands, including bacterial DNA or other endogenous mediators, stimulate Kupffer cells to produce IL-1␤. Secreted IL-1␤ acts on hepatocytes to increase lipid accumulation and cell death, causing steatosis and inflammation. IL-1␤ also stimulates HSCs to produce fibrogenic factors such as collagen and TIMP-1, resulting in fibrogenesis. Simultaneously, the TLR9-MyD88 axis promotes insulin resistance. TLR4 also contributes to this network in NASH as described previously. 4 
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dently of ATP in Kupffer cells. 39, 40 We suggest that TLR4 activates caspase-1 that cooperates with TLR9 to induce the active IL-1␤ in Kupffer cells. Then, IL-1␤ promotes lipid accumulation and cell death in hepatocytes and fibrogenic responses in HSCs (Figures 3 and 4) . However, IL-1R Ϫ/Ϫ mice had less of a reduction in liver injury, steatosis, and fibrosis than did MyD88 Ϫ/Ϫ mice (Figures 5 and 6 ). TNF-␣ may also contribute to the development of NASH in IL-1R Ϫ/Ϫ mice, because TNF-␣ is increased to similar levels in IL-1R Ϫ/Ϫ and WT mice (data not shown) but lower in MyD88 Ϫ/Ϫ mice. TNF-␣ is fibrogenic, by increasing TIMP-1 41 and decreasing Bambi expression in HSCs (data not shown).
Clinically, insulin resistance is strongly associated with the degree of NASH. [42] [43] [44] [45] [46] [47] However, recent studies have shown that an I148M mutation in patatin-like phospholipase domain-containing 3 protein (PNPLA3)/adiponutrin is associated with increased hepatic triglyceride content and ALT levels but independent of insulin resistance. 48 -51 In our study, both CSAA and CDAA diets induced a similar degree of insulin resistance as measured by HOMA-IR (Figure 7) . The CDAA diet resulted in a significant steatosis, inflammation, and fibrosis (Supplementary Figure 1; Supplementary Table 1 ), whereas the CSAA control diet led to a more modest degree of steatosis without inflammation and fibrosis (Supplementary Figure 1 ; Supplementary Table 1 ). These findings suggest that insulin resistance may be associated with some degree of steatosis but that the magnitude of the decreased insulin sensitivity in the current studies ( Figure 7 ) is insufficient to cause NASH.
Overall, the CDAA diet is a useful model to investigate NASH. The CDAA diet induces fibrosis, systemic insulin resistance, and weight gain in addition to steatohepatitis (Figure 7 ; Supplementary Figure 1 ; Supplementary Table 1) . These findings are compatible to the pathophysiology of human NASH. So far, 2 diet models are widely used for the study of steatohepatitis in rodents: high-fat diet and methionine and choline deficient (MCD) diet. A high-fat diet induces weight gain and systemic insulin resistance as in most cases of human NASH. However, the high-fat diet induces steatosis, but not inflammation and fibrosis. The MCD diet is most widely used for studying NASH. However, mice fed the MCD diet have weight loss without insulin resistance. 2, 52 In summary, we demonstrate a novel role for the innate immune system in mediating NASH. TLR9-MyD88 signaling mediates IL-1␤ production in Kupffer cells, which stimulates both hepatocytes and HSCs leading to the progression of NASH. Thus, the present study provides TLR9, MyD88, and IL-1␤ as a potential target for the therapy of NASH.
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